Does Centessa Pharmaceuticals PLC Sponsored ADR Have the Potential to Rally 40.85 percent as Wall Street Analysts Expect?
CNTA Stock | USD 17.04 1.02 5.65% |
About 67% of Centessa Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Centessa Pharmaceuticals PLC suggests that many traders are alarmed. The current market sentiment, together with Centessa Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Centessa Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Centessa |
The average of price targets set by Wall Street analysts indicates a potential upside of 40.9 percent in Centessa Pharmaceuticals PLC Sponsored ADR . While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Read at zacks.com
Centessa Pharmaceuticals Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Centessa Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Centessa Pharmaceuticals Fundamental Analysis
We analyze Centessa Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Centessa Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Centessa Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Centessa Pharmaceuticals is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Centessa Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Centessa Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Centessa Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Centessa Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Centessa Pharmaceuticals Related Equities
NAMSW | NewAmsterdam Pharma | 88.00 | ||||
IRON | Disc Medicine | 4.35 | ||||
CCCC | C4 Therapeutics | 2.86 | ||||
DSGN | Design Therapeutics | 1.69 | ||||
CRNX | Crinetics Pharmaceuticals | 0.97 | ||||
TARS | Tarsus Pharmaceuticals | 0.02 | ||||
ERAS | Erasca | 0.67 | ||||
NUVL | Nuvalent | 1.01 | ||||
OPT | Opthea | 1.10 | ||||
CGEM | Cullinan Oncology | 1.18 | ||||
MLYS | Mineralys Therapeutics, | 1.43 | ||||
GNFT | Genfit | 1.50 | ||||
EWTX | Edgewise Therapeutics | 2.58 | ||||
LRMR | Larimar Therapeutics | 2.81 | ||||
IPSC | Century Therapeutics | 4.08 | ||||
HLVX | Hillevax | 4.37 | ||||
TRDA | Entrada Therapeutics | 4.69 | ||||
GLUE | Monte Rosa | 7.45 | ||||
STRO | Sutro Biopharma | 16.37 |
Complementary Tools for Centessa Stock analysis
When running Centessa Pharmaceuticals' price analysis, check to measure Centessa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Centessa Pharmaceuticals is operating at the current time. Most of Centessa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Centessa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Centessa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Centessa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Stocks Directory Find actively traded stocks across global markets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |